Biotech Fonds Vlaanderen SA
Biotech Fonds Vlaanderen reported total assets of €24.6m at the end of the 2025 financial year (annual accounts filed with the NBB on 07 May 2026).
The score of Biotech Fonds Vlaanderen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -59 % Total assets -59 %
Accounts of the company itself (not consolidated).
The full file covers 14 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biotech Fonds Vlaanderen's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 May 2026
- Year ended 31 Dec 2024filed on 08 May 2025
- Year ended 31 Dec 2023filed on 17 May 2024
- Year ended 31 Dec 2022filed on 08 May 2023
- Year ended 31 Dec 2021filed on 13 May 2022
Biotech Fonds Vlaanderen's financial analysis
Management and control of Biotech Fonds Vlaanderen
Biotech Fonds Vlaanderen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0454.215.168
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Registered · 0208:0454215168 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Dec 1994
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 07 May 2026
Biotech Fonds Vlaanderen (SA) has been based in Brussels since 1994, active in: —. For 2025, it reports a net loss of €4.77m and equity of €24.5m; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biotech Fonds Vlaanderen
Companies in the same business, of comparable size and area, outside its group.
- Capricorn SCF Activities of holding companies Leuven · balance sheet €23.6m
- V-Bio Fund 2 Activities of money market and non-money market investments funds Ghent · balance sheet €51.8m
- Newton Biocapital I, pricaf privée de droit belge Activities of holding companies Woluwe-Saint-Pierre · balance sheet €59.5m
- White Fund Activities of holding companies Liège · balance sheet €26.0m
- Arteva Capital Activities of holding companies Waasmunster · balance sheet €25.3m
- Biogenosis Liège · balance sheet €16.4m
- Quaestor Biotech Activities of holding companies Roeselare · balance sheet €13.1m
- Qbic III Fund Activities of holding companies Ghent · balance sheet €38.5m
Frequently asked questions about Biotech Fonds Vlaanderen
What is the revenue of Biotech Fonds Vlaanderen?
Biotech Fonds Vlaanderen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biotech Fonds Vlaanderen?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Biotech Fonds Vlaanderen. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0454215168. Its company number (CBE) is 0454.215.168.
Where is the registered office of Biotech Fonds Vlaanderen?
According to the CBE register, the registered office of Biotech Fonds Vlaanderen is in 1000 Brussels.
What is the equity of Biotech Fonds Vlaanderen?
At the close of the 2025 financial year, the equity of Biotech Fonds Vlaanderen amounts to 24,519,885 €, a solvency of 99.9% of total assets.
Who manages Biotech Fonds Vlaanderen?
The register lists 4 active mandates at Biotech Fonds Vlaanderen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biotech Fonds Vlaanderen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →